openPR Logo
Press release

Global Cancer Diagnostics Market Analysis 2018 | Growth by Top Companies: MultiplexDx International, Cancer Diagnostics, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Illumina, Inc., Merck KGaA

11-05-2018 07:17 AM CET | IT, New Media & Software

Press release from: The Insight Partners

The Insight Partners

The Insight Partners

“Cancer Diagnostics Market" covers a detailed research on the industry with financial analysis of the major players. The report provides key information and detailed study relating to the industry along with the Economic Impact and Regulatory and Market Support. The report examines the industry synopsis, strategic investments, Industry Surveys, Economic Impact, etc.

The cancer diagnostics market of is expected to grow with a significant rate in the forecast years, owing to driving factors such as, increasing prevalence of cancer, technological improvements, public-private partnerships to improve the infrastructure of diagnostic imaging centers and FDA support for biomarker development. The companion diagnostics, personalized medicine are likely to offer more opportunities in the cancer diagnostics market.

Get Sample Pages at https://www.theinsightpartners.com/sample/TIPMD00002290

Diagnostic testing involves tests and procedures to confirm the presence of disease and identify the correct tumor type, location, extent and stage. The cancer diagnostics include sophisticated diagnostic technology to evaluate tumors and develop a personalized treatment plan. Some types of cancer, such as lymphomas, can be hard to classify, even for an expert. The method for the treatment and diagnosis of the disease depends on the patient and the severity of the cancer. The most common diagnostic methods include endoscopy, biopsy, diagnostic imaging and blood tests.

The “Global Cancer Diagnostics Market Analysis To 2025” is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global cancer diagnostics market with detailed market segmentation by technology, application and geography. The global cancer diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the cancer diagnostics market.

The global cancer diagnostics market is segmented on the basis of technology and application. The technology segment includes fluorescent in situ hybridization (FISH), comparative genomic hybridization (CGH), immunohistochemical (IHC) and others. The application segment is classified as breast cancer, lung cancer, melanoma, colorectal cancer and other cancers.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global cancer diagnostics market based on technology, application and geography. It also provides market size and forecast till 2025 for overall cancer diagnostics market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America is expected to contribute to the largest share in the cancer diagnostics market in the coming years, owing to factors such as, various market players operate in this region. The European region is expected to hold the second largest market for the cancer diagnostics. Asia Pacific is anticipated to be the fastest growing market as the due to the growing number of the cancer cases in the countries.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key cancer diagnostics market manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Illumina, Inc., Merck KGaA, GenScript, Cell Signaling Technology, Inc., PerkinElmer Inc., Cancer Diagnostics, Inc. and MultiplexDx International.

Access Complete Report at https://www.theinsightpartners.com/buy/TIPMD00002290

1. INTRODUCTION

2. KEY TAKEAWAYS

3. CANCER DIAGNOSTICS MARKET LANDSCAPE

4. CANCER DIAGNOSTICS MARKET – KEY INDUSTRY DYNAMICS

5. CANCER DIAGNOSTICS MARKET – GLOBAL ANALYSIS

6. CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 – BY TECHNOLOGY

7. CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 – BY APPLICATION

8. NORTH AMERICA CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 – COUNTRY ANALYSIS

9. EUROPE CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 – COUNTRY ANALYSIS

10. ASIA PACIFIC CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 – COUNTRY ANALYSIS

11. MIDDLE EAST AND AFRICA (MEA) CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 – COUNTRY ANALYSIS

13. CANCER DIAGNOSTICS MARKET, KEY COMPANY PROFILES

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Cancer Diagnostics Market Analysis 2018 | Growth by Top Companies: MultiplexDx International, Cancer Diagnostics, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Illumina, Inc., Merck KGaA here

News-ID: 1350810 • Views: 190

More Releases from The Insight Partners

Trade Finance Market – Detailed Analysis of Current Industry Figures with Fore …
The report presents the current market analysis scenario, future and future opportunities, revenue growth, prices and profitability. The proprietary data in this report is collected by Insight Partner’s dedicated research and analysis team of experienced professionals with advanced statistical expertise and various customization options in the existing study. Trade finance is a type of commercial activity that is closely associated with the story of human trade evolution. In trade businesses it
Lab Automation Industry Analysis by Top Players as Tecan Trading AG,, PerkinElme …
Lab Automation or Laboratory automation is a multi-disciplinary strategy to develop, research and optimize technologies in the clinical laboratory. Request a Sample PDF at https://www.theinsightpartners.com/sample/TIPHE100001249/?utm_source=OpenPR&utm_medium=Sumaiya The application of this technology in laboratories helps to achieve higher levels of performance in less time. Laboratory automation aids increasing productivity, reducing lab process cycle times, elevating experimental data quality and enabling easy experimentation. Moreover, the system includes development of the laboratory information (management) systems (LIS/LIMS)
Industrial Agitator Market SWOT Analysis and Segments from 2019-2027 | Xylem, SP …
According to the new research report published by The Insight Partners, titled “Industrial Agitator Market - Global Analysis and Forecast to 2027”, the global industrial agitator market is expected to reach US$ 4.65 Bn in 2027, registering a CAGR of 7.8% during the forecast period 2019-2027. Manufacturers from several industries are now a days highly focused on achieving new growth mark. Chemical industry is major revenue contributor to this market with
Security Screening Market Size, Share, Growth Analysis and Forecasts 2029-2027 | …
The global air travel industry is growing at a rapid pace. The factors such as high living standards coupled with rising middle class population particularly, in emerging markets has resulted in the increased growth. The global economic conditions as well as lower airfares are the major reason contributing to the growth. Also, progress in consumer spending related to tourism and travel in key economies has strengthened the demand for air

All 5 Releases


More Releases for CANCER

Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and